BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 23109135)

  • 21. Molecular and clinicopathological features of KIT/PDGFRA wild-type gastrointestinal stromal tumors.
    Nishida T; Naito Y; Takahashi T; Saito T; Hisamori S; Manaka D; Ogawa K; Hirota S; Ichikawa H
    Cancer Sci; 2024 Mar; 115(3):894-904. PubMed ID: 38178783
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Schipani A; Nannini M; Astolfi A; Pantaleo MA
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction.
    Nannini M; Astolfi A; Paterini P; Urbini M; Santini D; Catena F; Indio V; Casadio R; Pinna AD; Biasco G; Pantaleo MA
    Future Oncol; 2013 Jan; 9(1):121-6. PubMed ID: 23252569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications.
    Stratakis CA; Carney JA
    J Intern Med; 2009 Jul; 266(1):43-52. PubMed ID: 19522824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quadruple wild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways.
    Pantaleo MA; Nannini M; Corless CL; Heinrich MC
    Cancer Med; 2015 Jan; 4(1):101-3. PubMed ID: 25165019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor With SDHC Germline Mutation and Bilateral Renal and Neck Cysts.
    Stanley K; Friehling E; Davis A; Ranganathan S
    Pediatr Dev Pathol; 2019; 22(3):265-268. PubMed ID: 30301441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of succinate dehydrogenase subunit B (SDHB) expression is limited to a distinctive subset of gastric wild-type gastrointestinal stromal tumours: a comprehensive genotype-phenotype correlation study.
    Doyle LA; Nelson D; Heinrich MC; Corless CL; Hornick JL
    Histopathology; 2012 Nov; 61(5):801-9. PubMed ID: 22804613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild-type gastrointestinal stromal tumours.
    Wong NA; Wingate J; Gradhand E
    Histopathology; 2015 Sep; 67(3):378-85. PubMed ID: 25659413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.
    Miettinen M; Lasota J
    Int J Biochem Cell Biol; 2014 Aug; 53():514-9. PubMed ID: 24886695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KIT mutation in a naïve succinate dehydrogenase-deficient gastric GIST.
    Brcic I; Kashofer K; Skone D; Liegl-Atzwanger B
    Genes Chromosomes Cancer; 2019 Nov; 58(11):798-803. PubMed ID: 31124195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents.
    Ricci R; Martini M; Ravegnini G; Cenci T; Milione M; Lanza P; Pierconti F; Santini D; Angelini S; Biondi A; Rosa F; Alfieri S; Clemente G; Persiani R; Cassano A; Pantaleo MA; Larocca LM
    Clin Epigenetics; 2019 Jan; 11(1):2. PubMed ID: 30616628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST].
    Kelly L; Bryan K; Kim SY; Janeway KA; Killian JK; Schildhaus HU; Miettinen M; Helman L; Meltzer PS; van de Rijn M; Debiec-Rychter M; O'Sullivan M;
    PLoS One; 2013; 8(5):e64102. PubMed ID: 23717541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of immunohistochemical investigation of SDHB and molecular genetic analysis of SDH genes in the differential diagnosis of mesenchymal tumors of GIT.
    Dubova M; Sedivcova M; Michal M; Kokoskova B; Ryska A; Smid D; Daum O
    Histol Histopathol; 2015 Feb; 30(2):223-32. PubMed ID: 25205505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney-Stratakis dyad.
    Celestino R; Lima J; Faustino A; Máximo V; Gouveia A; Vinagre J; Soares P; Lopes JM
    Fam Cancer; 2012 Jun; 11(2):189-94. PubMed ID: 22160509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carney Triad, Carney-Stratakis Syndrome, 3PAS and Other Tumors Due to SDH Deficiency.
    Pitsava G; Settas N; Faucz FR; Stratakis CA
    Front Endocrinol (Lausanne); 2021; 12():680609. PubMed ID: 34012423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target.
    Pantaleo MA; Astolfi A; Di Battista M; Heinrich MC; Paterini P; Scotlandi K; Santini D; Catena F; Manara MC; Nannini M; Maleddu A; Saponara M; Lolli C; Formica S; Biasco G
    Int J Cancer; 2009 Dec; 125(12):2991-4. PubMed ID: 19672856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric gastrointestinal stromal tumor: Report of two novel patients harboring germline variants in SDHB and SDHC genes.
    Rinelli M; Agolini E; Milano GM; Russo I; Crocoli A; De Vito R; Di Giannatale A; Di Paolo PL; Novelli A
    Cancer Genet; 2020 Feb; 241():61-65. PubMed ID: 31883676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST.
    Urbini M; Astolfi A; Indio V; Nannini M; Schipani A; Bacalini MG; Angelini S; Ravegnini G; Calice G; Del Gaudio M; Secchiero P; Ulivi P; Gruppioni E; Pantaleo MA
    Sci Rep; 2020 Nov; 10(1):19829. PubMed ID: 33199729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
    Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
    Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.